Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article
This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & Sullivan - Novel cell and gene therapies, innovative drug delivery solutions and digital therapeutics for obesity, diabetes and CHF management to create growth opportunities, finds Frost & Sullivan
mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & Sullivan

 

PRTODAY - Newswire & PRZOOM/ - Santa Clara, CA, United States, 06/18/2018 - Novel cell and gene therapies, innovative drug delivery solutions and digital therapeutics for obesity, diabetes and CHF management to create growth opportunities, finds Frost & Sullivan.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Across the global cardiometabolic diseases landscape, the chronic heart failure (CHF) and obesity segments show the strongest increase with a compound annual growth rate (CAGR) of 36.1 percent and 23.0 percent, respectively, during the forecast period of 2017 to 2022. Wellness programs are expected to be an integral part of cardiometabolic disease treatment, in collaboration with clinical therapies. New business models such as direct-to-consumer (DTC) and telemonitoring services are supporting market players in reaching larger patient bases, especially across remote areas with inadequate treatment access.

Frost & Sullivan, in partnership with CMHC, has recently released its analysis, Cardiometabolic Diseases Market Trends & Growth Opportunities, which highlights future trends, key regulatory and pricing changes, growth opportunities, and the impact of innovative therapeutic solutions on the overall market in the next few years.

Future growth opportunities in the cardiometabolic market include:

• Regenerative Medicine: Cell and gene therapies for heart failure and diabetes are set to transform the therapeutic landscape with novel treatment solutions;
• Innovative Drug Delivery Solutions: A transition toward nanoparticles-based inhalable and subcutaneous drug delivery systems is anticipated; and
• Digital Therapeutics: mHealth platforms for diabetes, obesity and heart failure management will revolutionize value-based care paradigms.

“The entire cardiometabolic treatment paradigm is slowly shifting toward a ‘Therapy-as-a-Service Model’ with the integration of drug treatment with well-defined nutritional, behavioral and wellness programs, thus providing the patients with a holistic treatment,” noted Aarti Chitale, Global Transformational Health Senior Research Analyst at Frost & Sullivan.

Needs are not being met across the market due to a general lack of novel therapies, leading to increased collaborative drug development and commercialization activities. Leading players resort to mergers and acquisitions (M&As) with smaller niche players, thereby attaining therapeutic expertise as well as geographic expansion. Pfizer’s recent collaboration with Wave Life Sciences is aimed at developing genetically-targeted therapies from Wave’s RNA interference (RNAi) capabilities for metabolic diseases.

Additionally, other key market participants such as Novartis are investing in evidence-based/outcomes-based cost-benefit studies for high-value drugs such as Entresto™ to establish the cost-effectiveness of these therapies. The adoption of value-based payment (VBP) models closely aligns reimbursements to quality and overall outcomes of a treatment, thus reducing the economic burden on the patients, providers, and payers.

“While the cost of treatment has been an impeding issue across the market, industry players are increasingly adopting a value-based payment model by linking it to the therapeutic outcome of the drug, thereby addressing the challenges of higher drug costs and supporting a larger patient base,” observed Chitale.

Cardiometabolic Diseases Market Trends & Growth Opportunities is part of Frost & Sullivan’s Transformational Health Life Sciences Growth Partnership Service program.

About Frost & Sullivan

Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Cardiometabolic Diseases Market Trends & Growth Opportunities / MDB6_52

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRTODAY - Newswire Distribution Service Visibility Checker

 

Distribution / Indexing: [+] [Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & Sullivan

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRTODAY - Newswire Distribution Service and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Mariana Fernandez - Frost.com 
210-348-1012 mariana.fernandez[.]frost.com
 
Newswire Today - PRZOOM disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.

Health/Surgery via RSS
AddThis press release: mHealth for Diabetes and Heart Failure Will Revolutionize the Cardiometabolic Market Finds Frost & SullivanAdd Health/Surgery News to My MSNAdd Health/Surgery News to My Yahoo!Add NewswireToday Health/Surgery Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner

This article was published free of charge. Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read More Articles From Frost & Sullivan / Company Profile



Read Health/Surgery Most Recent Related Press Releases:

BeiGene Selects GE Healthcare’s Off-the-Shelf Biologics Factory to Boost its Manufacturing Capacity for Cancer Drugs
GE Global Research, DARPA Partner on $2.9 MM Project to Study New Treatments for Diabetes
NEOFECT Commended by Frost & Sullivan for Introducing NEOFECT RAPAEL, its Gamification-based Smart Rehabilitation Solutions
Supportive Regulation and Funding Models Required to Advance Population Health Management in Asia-Pacific Says Frost & Sullivan
South Carolina's Moterum Technologies Selected to Present at Prestigious Cavendish BioHealth Forum
Massachusetts Tech, Innovation, and Aging Service Leaders Launch Global Competition to Improve Healthy Aging
US Acute Care Solutions Expands Relationship with Centura Health
DiscGenics Engages CCRM and GE Healthcare to Support Scale-up Efforts for New Cell Therapy
SCBIO Presents PitchRounds At SEMDA MedTech Conference - South Carolina Inventors Convene to Present
Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion

Reserve This Permanent SPACE

Your LOGO permanently HERE on PRTODAY - Newswire Distribution Service most visited Page start at $295 per month

 
Sponsored Links


Visit  RightITnow, Inc.

Visit  BizJobs.com

Visit  medeuronet UK Ltd





Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



 
  ©2014 PRTODAY — Limelon Advertising, Co.
Home | About PRTODAY | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report news market search pr firms pr agencies business reports newswire today distri- bution investor relation successful internet entrepreneur free newswire distribution prtoday freenewswiredistribution.com asianewstoday bizwiretoday newswire pr today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)